Skip to main navigation Skip to search Skip to main content

Daratumumab depletes CD38(+) immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma

Research output: Contribution to journalArticleAcademicpeer-review

135 Downloads (Pure)
Original languageEnglish
Pages (from-to)384-394
JournalBlood
Volume128
Issue number3
DOIs
Publication statusPublished - 21 Jul 2016

Cite this